We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Genes2me is a genomics driven advanced diagnostic company creating a benchmark in the field of personalised healthcare and genetic screening with a focused segments into Preventive health, Oncology, Mother & Child health and Pharmacogenomics.
The translational approach to enhance global health even in resource limited areas by being cost effective, technologically driven, with a 360 degree overview of complete diagnostic proposition under one test.
Keeping innovation at the forefront and an access to clinically relevant samples having history, has backed Genes2me with insights into complex genetic diseases to ideate, create and evaluate to develop the best in class preventive, diagnostics and genetic based products and transform personalised Health.
Having state of the art facility established with all leading genomics and clinical diagnostics technologies installed and team of more than 75 experts in assay development, validation, scientific team, business development.